Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $455.00. The company's market cap stands at 249.12B, with a P/E ratio of 28.91 and a dividend yield of 2.14%.
On 2026-11-04, Amgen(AMGN) stock moved within a range of $448.08 to $467.88. With shares now at $455.00, the stock is trading +1.5% above its intraday low and -2.8% below the session's peak.
Trading activity shows a volume of 2.38M, compared to an average daily volume of 2.63M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $475.65 and a low of $294.48.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $475.65 and a low of $294.48.
AMGN News
For the quarter ended September 2026, Amgen (AMGN Quick QuoteAMGN - Free Report) reported revenue of $10.37 billion, up 8.5% over the same period last yea...
Amgen (AMGN Quick QuoteAMGN - Free Report) came out with quarterly earnings of $6.45 per share, beating the Zacks Consensus Estimate of $5.74 per share. T...
Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results 10/27/2026 Dow Jones biotech giant Amgen stock is trying to break out past a new buy poin...
Analyst ratings
51%
of 37 ratingsMore AMGN News
Amgen (NasdaqGS:AMGN) and the National Organization for Rare Disorders formed a rare autoimmune disease diagnosis Learning Collaborative involving multiple inst...
Analysts will be keenly tracking the top-line performance of Amgen’s (AMGN) established products, as they continue to see revenue erosion, when the firm reports...
This year has been a tremendous one for healthcare company Amgen (AMGN -0.22%), as it has risen by more than 40% in value thus far. While a lot of the hype in h...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Study Overview: Amgen Inc. (AMGN) is preparing a Phase 1 study titled “A Phase 1, Open-la...
The third-quarter 2026 reporting cycle for the Medical sector is in full swing, with most companies having already reported their results and several others sch...
Fresh trial data for IMDELLTRA in extensive stage small cell lung cancer and Tezspire in eosinophilic esophagitis has put Amgen (AMGN) back in the spotlight for...
Amgen reported in late October 2026 that Phase 3 data for IMDELLTRA in extensive stage small cell lung cancer and Tezspire in eosinophilic esophagitis showed st...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.